Trump hosts first public event since COVID-19 diagnosis, says virus will 'disappear' with 'science, medicine'
President Trump on Saturday hosted somewhere between 300 and 400 people on the South Lawn of the White House, marking his first public event since he was hospitalized after contracting COVID-19 last week. It's been just two weeks since a crowd gathered in the Rose Garden for Judge Amy Coney Barrett's Supreme Court nomination, which experts believe may have been the catalyst for a coronavirus outbreak that affected both the Trump administration and Republican senators.
Trump was scheduled to speak Saturday for about 30 minutes, but wound up only utilizing 18, an unusual instance of efficiency for the president, who is known for going on tangents that drift far beyond the scope of his planned marks. His voice reportedly sounded "a touch hoarse," but he showed no outward signs of illness and said he was "feeling great," The Associated Press reports.
During his speech, Trump said the coronavirus "is going to disappear" largely thanks to "science, medicine," and "the American spirit." That's a familiar line for the president, although this time the optimism appeared based in his belief that newly-developed coronavirus therapies, rather than wishful thinking, would lead the charge.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The event was not billed as a campaign rally, but the president's rhetoric suggested otherwise. Read more at Axios. Tim O'Donnell
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published